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Psychotherapy research rarely addresses the question of the ‘fit’ between person 
and treatment.  In this issue, Watzke and colleagues highlight the scarcity of 
knowledge about the individual characteristics that may make someone suitable 
for a particular form of therapy [1].  Yet as clinicians we spend a considerable 
amount of time attempting to identify what might work best for whom.  We often 
make research-based inferences from data about someone’s ‘suitability’ for an 
intervention on the basis of (a) effect sizes calculated from meta-analytic 
sensitivity analyses, (b) post hoc analyses of variables moderating treatment 
response rates in randomized controlled trials that compare two treatments, and 
(c) individual differences in response rates in trials that include only treatment-no 
treatment randomizations.  Even more problematic are inferences based on 
response rates from correlations of outcomes observed in cohort studies.  In 
most contexts statistical power is insufficient for a meaningful examination of 
moderator variables.  Post-hoc analyses are treacherous.  Trials are costly and 
pertinent replications are rare.  Predictors of good outcome in follow-along 
studies are not necessarily related to the treatment concerned.  Much of what is 
known about relative treatment effectiveness is focused around major diagnostic 
conditions. Even gross moderators such as gender, age and co-morbidity are 
rarely the subject of systematic, statistically valid studies.  Clinical judgment of 
suitability therefore continues to have an important role to play in this field. 
 
But are such judgements worthy of the name?  Mental health professionals tend 
to assume that they know what works for whom.  Given that the vast majority of 
psychotherapists believe themselves to be above average in terms of therapeutic 
effectiveness [2], conviction about competence cannot be considered sufficient 
grounds for accepting such judgements.  Personalised medicine is becoming 
extremely influential as we see treatments interacting with individual differences 
in tackling a disease process.  Psychotherapy may be light years away from such 
sophistication, given our lack of understanding of the therapeutic mechanisms by 
which treatments have their effects [3].  Yet, most therapists would claim to know 
intuitively what type of treatment is likely to lead to the best outcome, basing their 
judgements upon a constellation of demographic features, psychological 
capacities, clinical history including previous treatment response, contextual 
factors, personal goals in relation to treatment, and implicit naïve theories in 
relation to both treatment and treatment process that a particular individual 
presents to the referring clinician.  Given this range of parameters, let alone the 
practically infinite number of combinations in which they might occur, the chance 
of clinical decision-making of this sort having practical value may seem quite 
small.   
 
Notwithstanding the obvious barriers to informed judgement, the paper by 
Watzke and colleagues appears to find value in giving thought to what might 
work best for whom.  At least in the case of psychodynamic therapy, there 
appears to be a valid if implicit clinical algorithm that identifies some patients as 
more suitable than others for this type of treatment.  The findings suggest that 
this goes beyond superficial judgement of demography, although clearly 
demography does play a part, and points to indicators such as psychological-
mindedness, a wish to target the treatment beyond symptom removal and a 
concern with the antecedents as well as the relational contexts of the presenting 
problem.  These characteristics make psychodynamic psychotherapy an 
appropriate choice, at least for relatively short-term treatments assessed in terms 
of symptom distress six months after termination.  
 
Two further issues cry out for commentary. First, that CBT does as well or better 
when patients are randomized to this treatment arm  
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as when patients are systematically selected for it (pre-post ES: d(STS)=0.50, 
95%CI: 0.20-0.80 and d(RTS)=0.54, 95%CI: 0.11-0.96).  In other words, even 
when psychodynamic therapy appears particularly appropriate, it is no more 
effective than CBT, but when individuals are randomly allocated to this treatment, 
the outcomes can suffer.  By contrast, there appears to be no loss of 
effectiveness in randomly assigning individuals to CBT, even though presumably 
some of these individuals might initially have preferred another modality of 
treatment.  On the face of it the best outcomes appear to be associated with 
random assignment to CBT.  This is despite the fact that CBT in this arm loses 
some individuals who might be particularly suitable for a cognitive-behavioural 
treatment approach.  The relative benefit CBT patients receive from being 
randomised as opposed to assigned to that treatment, despite the reduced 
number of particularly well suited individuals, would be consistent with systematic 
treatment selection favouring psychodynamic treatment because the implicit 
algorithm ‘cherry picks’  for PDT those patients who are somewhat more likely to 
improve in symptom distress in any case.   
 
Second, patients randomly assigned to the psychodynamic arm of the protocol 
appeared to change little in terms of symptom distress, whereas those assigned 
to CBT showed substantial reduction of scores.  One does not wish to steal the 
authors’ thunder in relation to future publications, yet these findings, if robust, 
raise significant questions about a ‘Dodo bird’ verdict in relation to CBT and 
psychodynamic psychotherapy [4].  Unselected consecutive admissions appear 
better suited to a CBT approach, while psychodynamic therapy requires cases to 
be specifically chosen for this type of treatment.  Certainly, while there is no 
difference between pre-treatment means, six months following the end of 
treatment the difference between the means has an ES of around half a standard 
deviation (bias corrected d=0.52, 95% CI: 0.22-0.82).  This finding comes at a 
time when the movement behind gathering evidence for psychodynamic 
psychotherapy is gathering momentum to the point where it is hard to doubt the 
value of these methods when administered under reasonably controlled 
conditions [5, 6]. 
 
What makes Watzke et al.’s observations particularly important is the pragmatic 
nature of the trial - real clinicians working as they normally would with just a slight 
modification to their practice.  There may be a minor complication to these 
findings in that the first level of randomisation was only partially successful (for 
whatever reason, patients in the systematic treatment selection group had 
significantly higher initial symptom distress scores) but the statistical control 
leaves only slight doubt about comparability of the extent of change.  Unlike the 
frequently made claims that non-generalisable experimental methodology 
exaggerates claims for CBT, here naturalistic design evidently identifies 
weaknesses in PDT practice.  Previous experimental findings showing 
comparable effects of PDT and CBT in RCTs appear not to be generalisable to 
an unselected sample of patients in a busy outpatient clinic.  It is likely that the 
lacklustre mean treatment response to PDT in the RTS condition was composed 
of a number of positive treatment responses as well as some individuals whose 
response to PDT was one of worsening symptom distress.  To put it bluntly, 
unless patients are pre-screened for suitability they may be harmed by PDT as 
practised, at least by some psychotherapists working at this clinic.  
 
Is the need to be highly selective before referring for PDT the inevitable 
conclusion?  I think not.  It is my belief that the issue here is less of patient pre-
selection and more of routine psychotherapy practice.  The conceptual 
frameworks of PDT and CBT differ in that direct feedback about symptom 
change from patients forms the foundation of practice for clinicians practicing 
CBT but tends to be taken less literally by psychodynamic practitioners who are 
trained to focus on “process outcomes” (e.g. transferential responses, insight) 
that are believed to bring about symptomatic benefit.  Rather than making 
‘palliative’ suggestions about the inappropriateness of the outcome measure 
used [which has been used in many successful PDT trials – 7] or the lack of 
appropriate training of the PDT practitioners involved [they had more intensive 
training than most of the therapists in our trials – e.g. 8] or insufficiency of 
treatment duration [average treatment was longer than in most trials of short-term 
psychotherapy - 9] psychodynamic therapists should take these findings to heart 
as pointing to risks associated with the normal protocols for practising this 
(usually quite effective) therapy.  
 
The study helps us focus on the need to optimize the effectiveness of routine 
PDT practice by (1) more rigorous specification of therapeutic methods, including 
loose manualisation of routine psychodynamic treatment procedures, (2) closer 
attention to symptomatic as well as process aspects of treatment response in the 
course of a treatment, (3) attention to the overall effectiveness of individual 
practitioners and the provision of supervision and support for those whose 
outcomes are regularly below average.  One cannot help wondering if continuous 
(session by session) outcome monitoring by appropriate measures [such as the 
Schwartz, 10] might not have helped some of the patient-therapist pairs achieve 
better outcomes.  
 
Given that patients largely approach therapy with the aim of receiving help in 
relation to symptom distress, there is little room for special pleading.  We know 
that PDT is a highly efficacious treatment for a range of psychological disorders.  
However, when applied in the context of modern healthcare, uncritically 
implemented parameters of therapeutic psychodynamic practice inherited from 
the past century can yield disappointing results. Psychodynamic 
psychotherapists need to upgrade psychodynamic treatment protocols to 
address the needs of individuals who might otherwise appear to benefit only from 
a largely symptom-focused orientation.  
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